TABLE V.
Clinical characteristics of trajectory subtypes with max KDIGO 2.
| - | 2Im | 2St | 2St-1 | 2Ws |
|---|---|---|---|---|
|
| ||||
| Count | 836 | 551 | 94 | 391 |
| Inpatient Mortality - n (%) | 98 (11.72) | 151 (27.40) | 7 (7.45) | 177 (45.27) |
| Demographics | ||||
| Age - mean(SD) | 61.7 (15.9) | 64.4 (16.0) | 58.1 (15.4) | 61.2 (14.7) |
| Gender - male n(%) | 413 (49.4) | 291 (52.8) | 59 (62.8) | 243 (62.1) |
| Ethnic group - white n(%) | 780 (93.3) | 513 (93.1) | 90 (95.7) | 359 (91.8) |
| BMI - mean(SD) | 32.6 (11.4) | 31.7 (11.8) | 30.3 (7.9) | 30.3 (10.5) |
| Acuity of Critical Illness | ||||
| SOFA score - median[IQ1 - IQ3] | 9.0 (6.0– 11.0) | 9.0 (6.0– 11.0) | 9.0 (6.0– 10.0) | 9.0 (6.0– 10.0) |
| APACHE score - median[IQ1 - IQ3] | 25.0 (21.0– 28.0) | 25.0 (21.5– 29.0) | 24.0 (21.0– 27.0) | 25.0 (21.0– 28.0) |
| AKI characteristics | ||||
| ALL Baseline SCr - median[IQ1 - IQ3] | 0.9 (0.8– 1.0) | 0.9 (0.8– 1.0) | 0.9 (0.8– 1.0) | 1.0 (0.8– 1.0) |
| ALL Baseline eGFR - median[IQ1 - IQ3] | 68.8 (55.3– 74.6) | 61.2 (55.3– 74.6) | 61.9 (55.3– 74.6) | 55.3 (55.3– 74.6) |
| Measured Baselines - n (%) | 218 (26.1) | 107 (19.4) | 39 (41.5) | 120 (30.7) |
| Measured Baseline SCr - median[IQ1 - IQ3] | 0.8 (0.7– 1.1) | 0.8 (0.7– 1.0) | 0.8 (0.7– 1.0) | 0.9 (0.7– 1.1) |
| Measured Baseline eGFR - median[IQ1 - IQ3] | 69.3 (54.0– 88.2) | 74.8 (55.3– 89.5) | 71.7 (58.0– 87.6) | 65.8 (48.9– 85.1) |
| Imputed Baseline SCr - median[IQ1 - IQ3] | 0.9 (0.8– 1.0) | 0.9 (0.8– 1.0) | 1.0 (0.9– 1.0) | 1.0 (0.8– 1.0) |
| Imputed Baseline eGFR - median[IQ1 - IQ3] | 61.5 (55.3– 74.6) | 55.3 (55.3– 74.6) | 55.3 (55.3– 74.6) | 55.3 (55.3– 74.6) |
| Admit SCr - median[IQ1 - IQ3] | 2.0 (1.6– 2.3) | 1.9 (1.6– 2.4) | 1.0 (0.8– 1.2) | 1.2 (0.9– 1.5) |
| Peak SCr - median[IQ1 - IQ3] | 2.1 (1.8– 2.5) | 2.4 (2.1– 2.9) | 2.1 (1.8– 2.5) | 2.2 (1.9– 2.6) |
| Maximum KDIGO Stage - Whole ICU: | ||||
| Stage 1 - n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Stage 2 - n (%) | 764 (45.9) | 391 (23.5) | 81 (4.9) | 345 (20.7) |
| Stage 3 - n (%) | 53 (4.7) | 142 (12.6) | 13 (1.2) | 19 (1.7) |
| Stage 3D - n (%) | 19 (1.8) | 18 (1.7) | 0 (0.0) | 27 (2.5) |
| Maximum KDIGO Stage – 7 Days: | ||||
| Stage 1 - n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Stage 2 - n (%) | 788 (47.2) | 421 (25.2) | 84 (5.0) | 377 (22.6) |
| Stage 3 - n (%) | 47 (4.2) | 130 (11.6) | 10 (0.9) | 9 (0.8) |
| Stage 3D - n (%) | 1 (0.1) | 0 (0.0) | 0 (0.0) | 5 (0.6) |
| Urine output D0-D2 - median[IQ1 - IQ3] | 1.7 (1.0– 2.6) | 1.4 (0.8– 2.3) | 1.5 (1.0– 2.6) | 1.3 (0.8– 2.3) |
| Urine flow D0-D2 - median[IQ1 - IQ3] | 0.8 (0.5– 1.3) | 0.7 (0.4– 1.2) | 0.7 (0.4– 1.4) | 0.6 (0.4– 1.0) |